Search PubMed⌕ Search

Biomedical subjects

J Espinosa

Publications and source records attributed to J Espinosa.

80 records · Page 5Linked to original sources
PubMedDate not supplied

Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico.

In the search for early biological markers to detect genetic damage, a pilot study on a hydroarsenicism-exposed group was designed. Blood and urine samples were taken from 11 individuals chronically exposed and from 13 individuals with lower exposure to the metal. Lymphocyte cultures for cytogenetic studies and HGPRT assay were done with coded peripheral blood samples, while arsenic levels and the "rec assay" in B. subtilis were determined in urine samples. The highly exposed group excreted greater amounts of As, nevertheless the rec assay showed negative results. An interesting finding is that the cell-cycle kinetics exhibited a significant difference between the groups studied, the average generation time (AGT) was longer in the highly exposed group. The percentages of chromosomal aberrations and the frequencies of sister-chromatid exchanges were similar in both populations, although complex aberrations were more frequent in the highly exposed group, which also showed a higher average variation frequency in the HGPRT assay, but the 2 latter observations were not statistically significant. The lag in lymphocyte proliferation could mean an impairment of the immune response due to arsenic exposure.

Adult↗
PubMedDate not supplied

A case study of an outbreak of African swine fever in Spain.

This report represents a case study of an outbreak of African swine fever (ASF) that took place in the autonomic region of Extramadura, Badajoz Province, during the month of August, 1992, and aims to describe the Spanish ASF eradication programme as carried out in the field at producer level. Extensive husbandry methods used in the management of Iberian pigs in ASF endemic areas of Spain (about 4% of Spanish territory in 4/52 provinces) makes eradication particularly difficult. Since there is no vaccine available for ASF, the identification and slaughter of carrier animals is crucial to the control of the disease. A case of ASF, which caused one secondary outbreak, was diagnosed on 26 August 1992 and is described in terms of case history, laboratory examination, disease eradication measures and epidemiological observations. Additional evidence is presented in an attempt to evaluate and gain an understanding of the long-term risk of carrier animals, wild European pigs, vector ticks and biting flies as a cause of the persistence in endemic areas of recrudescence of ASF in areas from which the disease was previously eradicated.

African Swine Fever↗
PubMedDate not supplied

Control of Trypanosoma cruzi epimastigote motility through the nitric oxide pathway.

Trypanosoma cruzi epimastigote motility can be enhanced by addition of L-arginine, to the culture. This effect is blocked by N-methyl-L-arginine, a competitive inhibitor of the nitric oxide synthase. N-methyl-D-aspartate and L-glutamate, two agonists of the NMDA/L-glutamate receptor, also enhanced motility. This stimulation is blocked by MK-801 a noncompetitive antagonist of the NMDA receptor. In addition, sodium nitroprusside, a guanylyl cyclase stimulator and 8-Br-cyclic GMP, and analog of cyclic GMP, also stimulated epimastigote motility. It is suggested that an increase of intracellular cyclic GMP levels mediated by nitric oxide may be responsible for the increase in epimastigote motility.

Amino Acids↗
PubMedDate not supplied

Factors from Trypanosoma cruzi interacting with AP-1 sequences.

Interaction between factors from Trypanosoma cruzi extracts and AP-1 sequences was studied by electrophoretic mobility shift assays. Using a double-stranded probe carrying the AP-1 sequence from the SV40 promoter, three specific complexes designated A, B, and C were detected. Complexes A and C were formed when using single-stranded probes. The relative amount of complex B, specific for double-stranded DNA, increased as a function of probe length. Complexes were stabilized by cross-linking with UVC irradiation and resolved on denaturing SDS-PAGE. Complex A generated bands of 60- and 39 kDa; complex B produced two bands of 46- and 43 kDa; and complex C generated one band of 43 kDa. The AP-1 binding activity was much higher in purified nuclear preparations than in soluble fractions, and was detected in crude extracts from the three forms of the parasite. The binding signal, however, was much stronger in amastigote and trypomastigote than in the epimastigote forms. Specific binding was increased by oxidative stress. Antibodies raised against peptides corresponding to conserved domains of mammalian c-Jun and c-Fos detected bands of 40- and 60 kDa, respectively, in a nuclear epimastigote preparation.

Animals↗
PubMedDate not supplied

Strategies to prevent failure of the new paradigm.

Despite the hopes, hard work, and research of many in healthcare, the long-term success of the new paradigm of continuous quality improvement (CQI) is far from assured. The authors suggest that the premature demise of CQI in healthcare is a possibility unless certain trends and forces are addressed and altered. Six challenges to the long-term viability of CQI are discussed in this article along with practical strategies to protect the integrity and vitality of the movement.

Forecasting↗